Evidence map›Paper›PMID 33763141›Full record

ArticleStem cells international2021

Exosomes from Kartogenin-Pretreated Infrapatellar Fat Pad Mesenchymal Stem Cells Enhance Chondrocyte Anabolism and Articular Cartilage Regeneration.

Jiahua Shao, Jun Zhu, Yi Chen, Qiwei Fu, Lexiang Li, Zheru Ding, Jun Wu, Yaguang Han, Haobo Li, Qirong Qian and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. [Research progress of infrapatellar fat pad derived mesenchymal stem cells in treatment of osteoarthritis].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Review
  2. [Application of Kartogenin in cartilage tissue engineering].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jiahua ShaoDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0002-7324-1812
Jun ZhuDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0002-0859-3483
Yi ChenDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0002-9084-0657
Qiwei FuDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0003-3775-8248
Lexiang LiDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0001-8028-2148
Zheru DingDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0001-8304-0208
Jun WuDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0003-2024-0792
Yaguang HanDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0003-3861-3358
Haobo LiDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0002-1234-4412
Qirong QianDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0002-6867-1666
Yiqin ZhouDepartment of Orthopedics, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200003, China.ORCID https://orcid.org/0000-0001-6479-4020
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the effect of Kartogenin-pretreated exosomes derived from infrapatellar fat pad mesenchymal stem cells on chondrocyte in vitro and articular cartilage regeneration in vivo.

methodsInfrapatellar fat pad mesenchymal stem cells (IPFP-MSCs) were isolated from rabbits to harvest exosomes. After identification of mesenchymal stem cells and exosomes, rabbit chondrocytes were divided into three groups for further treatment: the EXO group (chondrocytes treated with exosomes isolated from infrapatellar fat pad mesenchymal stem cells), KGN-EXO group (chondrocytes treated with exosomes isolated from infrapatellar fat pad mesenchymal stem cells pretreated with KGN), and control group. After processing and proliferation, phenotypic changes of chondrocytes were measured. In the in vivo study, 4 groups of rabbits with articular cartilage injury were treated with KGN-EXO, EXO, IPFP-MSCs, and control. Macroscopic evaluation and histological evaluation were made to figure out the different effects of the 4 groups on cartilage regeneration in vivo.

resultsThe proliferation rate of chondrocytes in the EXO or KGN-EXO group was significantly higher than that in the control group (

conclusionOur study demonstrates that the exosomes isolated from infrapatellar fat pad mesenchymal stem cells pretreated with KGN have potent ability to induce chondrogenic differentiation of stem cells, effectively promoting the proliferation and the expression of chondrogenic proteins and genes of chondrocytes. The KGN-EXO can also promote the repair of articular cartilage defects more effectively, which can be used as a potential therapeutic method in the future.

Identifiers

PMID33763141
PMCPMC7964125
OpenAlexW3133857126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.